Stage III Bladder Cancer AJCC v8 Active Not Recruiting Phase 2 Trials for Avelumab (DB11945)

Indication	Status	Phase
DBCOND0109731 (Stage III Bladder Cancer AJCC v8)	Active Not Recruiting	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT03617913	Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer	Treatment	Avelumab (DB11945) Carboplatin (DB00958) Chloride ion (DB14547) Cisplatin (DB00515) Fluorouracil (DB00544) Mitomycin (DB00305) Platinum (DB12257)